Compare · LUCY vs STAA
LUCY vs STAA
Side-by-side comparison of Innovative Eyewear Inc. (LUCY) and STAAR Surgical Company (STAA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LUCY and STAA operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- STAA is the larger of the two at $1.19B, about 248.2x LUCY ($4.8M).
- Over the past year, LUCY is down 66.0% and STAA is up 34.8% - STAA leads by 100.8 points.
- LUCY has been more active in the news (5 items in the past 4 weeks vs 1 for STAA).
- STAA has more recent analyst coverage (25 ratings vs 0 for LUCY).
- Company
- Innovative Eyewear Inc.
- STAAR Surgical Company
- Price
- $0.74-7.47%
- $23.96-9.28%
- Market cap
- $4.8M
- $1.19B
- 1M return
- -15.83%
- -17.80%
- 1Y return
- -66.02%
- +34.79%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- News (4w)
- 5
- 1
- Recent ratings
- 0
- 25
STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Latest LUCY
- Innovative Eyewear, Inc. Announces New Claude AI Integration for All Lucyd Smart Eyewear
- Innovative Eyewear Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds
- Innovative Eyewear, Inc. Announces 345-Store Rollout with FYihealth Group
- Innovative Eyewear Q2 2026 Net Sales Up 71% Year-Over-Year in Twelfth Consecutive Quarter of Growth
- Innovative Eyewear, Inc. Partners with Encore Optical Laboratory to Provide New Lens Technologies for Smart Eyewear
- Innovative Eyewear Inc. Reports Q1 2026 Unaudited Financial Results
- SEC Form 10-Q filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Announces Real-Time AI Translated Calls for the Lucyd App
- Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.
Latest STAA
- STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026
- SEC Form S-8 filed by STAAR Surgical Company
- SEC Form 4 filed by Director Wang Christopher Min Fang
- SEC Form 4 filed by Director Lebuhn Richard T.
- SEC Form 4 filed by Director Bradsher Neal C
- Director Butcher Arthur C converted options into 5,341 shares, increasing direct ownership by 127% to 9,549 units (SEC Form 4)
- SEC Form 4 filed by Director Zhou Lilian Yansheng
- STAAR Surgical Company filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Silverman Lou converted options into 10,683 shares, increasing direct ownership by 2,249% to 11,158 units (SEC Form 4)
- Director Jiang Wei converted options into 10,683 shares, increasing direct ownership by 16% to 77,127 units (SEC Form 4)